Progress from Royal Liver has improved its Critical Illness Cover (CIC) product by increasing the number of illnesses covered and expanding the range of cover for a number of definitions.
It has been designed to give IFAs more choice when discussing CIC with their clients. According to Progress, the changes to the proposition are built on IFA and consumer feedback. It adds that the alterations clarify the definition of critical illness, while the extra coverage will improve the overall value for money proposition of the product.
Around 40 illnesses will now be covered, including nine new conditions: bacterial meningitis, cardiomyopathy, encephalitis, open heart surgery, primary pulmonary hypertension, progressive supranuclear palsy, pulmonary artery surgery, chronic and severe rheumatoid arthritis and systematic lupus erythematosus .
Mike Farrell, head of sales and marketing at progress from Royal Liver, said: "Not only are we extending the level of protection on offer, were keeping our price incredibly competitive, which has to be a good thing."




